|
|
|
Insider
Information: |
Caforio Giovanni |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
435,474 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,903,062 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
435,474 |
|
|
Total
Value |
$18,903,062 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
1.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
Executive Chair of the... |
2024-03-10 |
432,266 |
|
0 |
Premium* |
|
Stryker Corp |
SYK |
Director |
2024-05-09 |
3,208 |
2023-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
Pres., US PharmaceuticalsOffic |
|
2011-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38,818 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
46,318 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-01-03 |
4 |
D |
$35.01 |
$125,301 |
D/D |
(3,579) |
42,739 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,493 |
44,232 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
404 |
44,636 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-01 |
4 |
D |
$32.64 |
$22,522 |
D/D |
(690) |
43,946 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-02 |
4 |
D |
$32.59 |
$18,739 |
D/D |
(575) |
44,952 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
384 |
45,527 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,197 |
45,143 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,851 |
46,803 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-03 |
4 |
D |
$32.59 |
$21,933 |
D/D |
(673) |
46,130 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,517 |
47,647 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-04 |
4 |
D |
$32.59 |
$17,990 |
D/D |
(552) |
47,095 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,811 |
55,906 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-06 |
4 |
D |
$32.33 |
$103,585 |
D/D |
(3,204) |
52,702 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-08-24 |
4 |
S |
$32.69 |
$846,671 |
D/D |
(25,900) |
57,260 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-08-24 |
4 |
OE |
$23.18 |
$705,925 |
D/D |
30,458 |
83,160 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
64,760 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-01-03 |
4 |
D |
$33.24 |
$96,728 |
D/D |
(2,910) |
61,850 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-01-28 |
4 |
OE |
$28.67 |
$645,075 |
D/D |
22,500 |
84,350 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-01-28 |
4 |
S |
$36.19 |
$736,467 |
D/D |
(20,350) |
64,000 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-02-27 |
4 |
S |
$37.08 |
$450,522 |
D/D |
(12,150) |
51,850 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-03-03 |
4 |
D |
$37.15 |
$25,634 |
D/D |
(690) |
53,011 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,851 |
53,701 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,482 |
68,493 |
0 |
- |
|
119 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|